Prevention of COPD Readmissions: A Work in Progress
- PMID: 28003558
- DOI: 10.4187/respcare.05350
Prevention of COPD Readmissions: A Work in Progress
Comment on
-
A Respiratory Therapist Disease Management Program for Subjects Hospitalized With COPD.Respir Care. 2017 Jan;62(1):1-9. doi: 10.4187/respcare.05030. Epub 2016 Nov 29. Respir Care. 2017. PMID: 27899531 Clinical Trial.
Similar articles
-
Chronic Obstructive Pulmonary Disease Readmissions and Other Measures of Hospital Quality.Am J Respir Crit Care Med. 2017 Jul 1;196(1):47-55. doi: 10.1164/rccm.201609-1944OC. Am J Respir Crit Care Med. 2017. PMID: 28145726 Free PMC article.
-
Evaluation of prediction strategy and care coordination for COPD readmissions.Hosp Pract (1995). 2016 Aug;44(3):123-8. doi: 10.1080/21548331.2016.1210472. Epub 2016 Jul 19. Hosp Pract (1995). 2016. PMID: 27391991
-
Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.Ann Am Thorac Soc. 2016 Feb;13(2):197-203. doi: 10.1513/AnnalsATS.201507-439OC. Ann Am Thorac Soc. 2016. PMID: 26599286 Free PMC article.
-
Evaluation of Chronic Obstructive Pulmonary Disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?Respir Med. 2016 Oct;119:135-140. doi: 10.1016/j.rmed.2016.09.008. Epub 2016 Sep 8. Respir Med. 2016. PMID: 27692135 Clinical Trial.
-
Continuity of care and its effect on readmissions for COPD patients: A comparative study of Norway and Germany.Health Policy. 2018 Jul;122(7):737-745. doi: 10.1016/j.healthpol.2018.05.013. Epub 2018 May 26. Health Policy. 2018. PMID: 29933893 Review.
Cited by
-
A randomised controlled feasibility trial of E-health application supported care vs usual care after exacerbation of COPD: the RESCUE trial.NPJ Digit Med. 2020 Oct 30;3:145. doi: 10.1038/s41746-020-00347-7. eCollection 2020. NPJ Digit Med. 2020. PMID: 33145441 Free PMC article.
-
Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment.Int J Chron Obstruct Pulmon Dis. 2019 May 15;14:1019-1031. doi: 10.2147/COPD.S199251. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31190787 Free PMC article.
-
30-Day Readmission Rate of Patients with COPD and Its Associated Factors: A Retrospective Cohort Study from a Tertiary Care Hospital.Int J Chron Obstruct Pulmon Dis. 2023 Nov 16;18:2623-2631. doi: 10.2147/COPD.S429108. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 38022826 Free PMC article.
-
Incidence, Predictors, Causes, and Cost of 30-Day Hospital Readmission in Chronic Obstructive Pulmonary Disease Patients Undergoing Bronchoscopy.Cureus. 2020 Jun 13;12(6):e8607. doi: 10.7759/cureus.8607. Cureus. 2020. PMID: 32550091 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical